Literature DB >> 18978041

Preferential physical and functional interaction of pregnane X receptor with the SMRTalpha isoform.

Chia-Wei Li1, Gia Khanh Dinh, J Don Chen.   

Abstract

The silencing mediator for retinoid and thyroid hormone receptors (SMRT) serves as a platform for transcriptional repression elicited by several steroid/nuclear receptors and transcription factors. SMRT exists in two major splicing isoforms, alpha and tau, with SMRTalpha containing only an extra 46-amino acid sequence inserted immediately downstream from the C-terminal corepressor motif. Little is known about potential functional differences between these two isoforms. Here we show that the pregnane X receptor (PXR) interacts more strongly with SMRTalpha than with SMRTtau both in vitro and in vivo. It is interesting that the PXR-SMRTalpha interaction is also resistant to PXR ligand-induced dissociation, in contrast to the PXR-SMRTtau interaction. SMRTalpha consistently inhibits PXR activity more efficiently than does SMRTtau in transfection assays, although they possess comparable intrinsic repression activity and association with histone deacetylase. We further show that the mechanism for the enhanced PXR-SMRTalpha interaction involves both the 46-amino acid insert and the C-terminal corepressor motif. In particular, the first five amino acids of the SMRTalpha insert are essential and sufficient for the enhanced binding of SMRTalpha to PXR. Furthermore, we demonstrate that Tyr2354 and Asp2355 residues of the SMRTalpha insert are most critical for the enhanced interaction. In addition, expression data show that SMRTalpha is more abundantly expressed in most human tissues and cancer cell lines, and together these data suggest that SMRTalpha may play a more important role than SMRTtau in the negative regulation of PXR.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18978041      PMCID: PMC2629818          DOI: 10.1124/mol.108.047845

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  39 in total

Review 1.  Nuclear receptor coactivators.

Authors:  S Westin; M G Rosenfeld; C K Glass
Journal:  Adv Pharmacol       Date:  2000

2.  The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors.

Authors:  X Hu; M A Lazar
Journal:  Nature       Date:  1999-11-04       Impact factor: 49.962

Review 3.  Regulation of SMRT and N-CoR corepressor function.

Authors:  M L Privalsky
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

4.  The human homologue of the yeast DNA repair and TFIIH regulator MMS19 is an AF-1-specific coactivator of estrogen receptor.

Authors:  X Wu; H Li; J D Chen
Journal:  J Biol Chem       Date:  2001-03-28       Impact factor: 5.157

5.  The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux.

Authors:  T W Synold; I Dussault; B M Forman
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

6.  A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness.

Authors:  M G Guenther; W S Lane; W Fischle; E Verdin; M A Lazar; R Shiekhattar
Journal:  Genes Dev       Date:  2000-05-01       Impact factor: 11.361

7.  Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin.

Authors:  A Geick; M Eichelbaum; O Burk
Journal:  J Biol Chem       Date:  2001-01-31       Impact factor: 5.157

8.  Xenobiotic induction of cytochrome P450 2B1 (CYP2B1) is mediated by the orphan nuclear receptor constitutive androstane receptor (CAR) and requires steroid co-activator 1 (SRC-1) and the transcription factor Sp1.

Authors:  R Muangmoonchai; D Smirlis; S C Wong; M Edwards; I R Phillips; E A Shephard
Journal:  Biochem J       Date:  2001-04-01       Impact factor: 3.857

Review 9.  The SRC family of nuclear receptor coactivators.

Authors:  C Leo; J D Chen
Journal:  Gene       Date:  2000-03-07       Impact factor: 3.688

10.  Sequestration and inhibition of Daxx-mediated transcriptional repression by PML.

Authors:  H Li; C Leo; J Zhu; X Wu; J O'Neil; E J Park; J D Chen
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

View more
  8 in total

1.  Rifampicin-independent interactions between the pregnane X receptor ligand binding domain and peptide fragments of coactivator and corepressor proteins.

Authors:  Punya Navaratnarajah; Bridgett L Steele; Matthew R Redinbo; Nancy L Thompson
Journal:  Biochemistry       Date:  2011-12-20       Impact factor: 3.162

Review 2.  Phosphorylation and protein-protein interactions in PXR-mediated CYP3A repression.

Authors:  Satyanarayana R Pondugula; Hanqing Dong; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-08       Impact factor: 4.481

Review 3.  Activation of pregnane X receptor (PXR) and constitutive androstane receptor (CAR) by herbal medicines.

Authors:  Thomas K H Chang
Journal:  AAPS J       Date:  2009-08-18       Impact factor: 4.009

4.  Phosphorylation Modulates the Coregulatory Protein Exchange of the Nuclear Receptor Pregnane X Receptor.

Authors:  Wenqi Cui; Xunan Shen; Emre Agbas; Brandon Tompkins; Hadley Cameron-Carter; Jeff L Staudinger
Journal:  J Pharmacol Exp Ther       Date:  2020-03-23       Impact factor: 4.030

5.  Pregnane-x-receptor controls hepatic glucuronidation during pregnancy and neonatal development in humanized UGT1 mice.

Authors:  Shujuan Chen; Mei-Fei Yueh; Ronald M Evans; Robert H Tukey
Journal:  Hepatology       Date:  2012-06-11       Impact factor: 17.425

Review 6.  Pregnane X Receptor (PXR)-Mediated Gene Repression and Cross-Talk of PXR with Other Nuclear Receptors via Coactivator Interactions.

Authors:  Petr Pavek
Journal:  Front Pharmacol       Date:  2016-11-25       Impact factor: 5.810

7.  The pregnane X receptor (PXR) and the nuclear receptor corepressor 2 (NCoR2) modulate cell growth in head and neck squamous cell carcinoma.

Authors:  Juan Pablo Rigalli; Matthias Reichel; Tasmin Reuter; Guillermo Nicolás Tocchetti; Gerhard Dyckhoff; Christel Herold-Mende; Dirk Theile; Johanna Weiss
Journal:  PLoS One       Date:  2018-02-22       Impact factor: 3.240

Review 8.  PXR: a center of transcriptional regulation in cancer.

Authors:  Yaqi Xing; Jiong Yan; Yongdong Niu
Journal:  Acta Pharm Sin B       Date:  2019-06-29       Impact factor: 11.413

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.